SSI Investment Management’s Bristol-Myers Squibb BMY Stock Holding History
Bought
Maintained
Sold
Other funds holding BMY
SSI Investment Management's BMY Position: Q2 2023 in Review
SSI Investment Management sold out of Bristol-Myers Squibb (BMY) in Q2 2023, closing a stake of 3,211 shares — an estimated $223K sold.
SSI Investment Management first reported a position in BMY in Q2 2013 and held it in 20 quarters. The position peaked at $650K in Q4 2013. 2,480 funds tracked by Wall St. Rank hold BMY as of Q2 2023.
- SSI Investment Management reported no remaining Bristol-Myers Squibb position as of Q2 2023 after selling out during the quarter.
- SSI Investment Management sold 3,211 Bristol-Myers Squibb shares in Q2 2023, an estimated $223K.
- SSI Investment Management first reported a position in Bristol-Myers Squibb in Q2 2013 and held it in 20 quarters.
- SSI Investment Management's Bristol-Myers Squibb position peaked at $650K in Q4 2013.
- 2,480 funds tracked by Wall St. Rank held Bristol-Myers Squibb as of Q2 2023.
Based on SSI Investment Management's 13F filing for Q2 2023, filed 9 Aug 2023.